Human Gene Therapy Subcommittee - 11/30/90 
Ad hoc Consultant: 
Barbara E. Murray, University of Texas Health Science Center 
Executive Secretaiy: 
Nelson A. Wivel, National Institutes of Health 
National Institutes of Health staff: 
W. French Anderson, NHLBI 
R. Michael Blaese, NCI 
Christine Ireland, OD 
Becky Lawson, OD 
Pete Peters, OD 
Steven A. Rosenberg, NCI 
Diane Striar, NHLBI 
Others: 
M. James Barrett, Genetic Therapy, Inc. 
Virginia L. Baskerville, NIH Observer 
Malcolm K. Brenner, St. Jude Children's Research Hospital 
Quan Cai, Pittsburgh Cancer Institute 
Yawen Chiang, Genetic Therapy, Inc. 
Kenneth Cornetta, University of Wisconsin-Madison 
Elaine Elder, Pittsburgh Cancer Institute 
Robin Henig, New York Times Magazine 
Freddie Hoffman, Food and Drug Administration 
James Ihle, St. Jude Children's Research Hospital 
Attila Kadar, Food and Drug Administration 
Fred Ledley, Baylor College of Medicine 
Michael T. Lotze, Pittsburgh Cancer Institute 
Paul Mied, Biotronics Systems 
Joseph Mirro, Jr., St. Jude Children's Research Hospital 
Robert C. Moen, Genetic Therapy, Inc. 
Jeff Morgan, Somatk Corporation 
Robert Overell, Immunex Corporation 
Eugenia Chambers Stoner, University of Pittsburgh 
Paul Tolstoshev, Genetic Therapy, Inc. 
George Wallrodt, StenoTech, Inc. 
[372] 
Recombinant DNA Research, Volume 14 
